US NYSE

McKesson & Robbins, Inc. (1938)

Pharmaceutical distributor whose $19M phantom crude-drug inventory scam led the SEC and AICPA to mandate physical inventory observation and receivables confirmation.

CORPORATE IDENTIFIERS & DOSSIER
  • Entity Name: McKesson & Robbins, Inc. (1938)
  • Country of Domicile: US
  • Listing & Ticker: NYSE (MCK).
  • CIK / LEI Identifier: Unregistered.
  • Industry Classification: Drugs, Proprietaries, and Sundries (SIC 5122).
  • Cumulative Overstatement: $19.0M across 1 enforcement episode(s).
  • Assessed Penalties: $0.

PRIMARY ENFORCEMENT CASES INVOLVING MCKESSON & ROBBINS, INC. (1938)

1 CASE DOSSIERS
Case Title Status Primary Scheme Overstatement Total Penalties Action Date
McKesson & Robbins: $19M Phantom Crude-Drug Inventory & Audit Standards Reform Adjudicated phantom inventory $19.0M $0 September 20, 1940

FORENSIC PROFILE: MCKESSON & ROBBINS: $19M PHANTOM CRUDE-DRUG INVENTORY & AUDIT STANDARDS REFORM

FULL CASE DOSSIER →

Falsified $19M in non-existent crude-drug inventories and fictitious Canadian warehouse receivables via sham intermediaries, prompting the SEC to mandate physical inventory observation.

The company manipulated its accounting records by executing schemes under phantom-inventory. Financial reports filed with market regulators contained material misstatements that distorted true financial condition.

Fraud Window: January 1, 1938 to December 31, 1940 • Primary Regulator: U.S. Securities and Exchange Commission • Auditor: PricewaterhouseCoopers LLP

Documented Accounting Irregularities & Regulatory Findings

  • PHANTOM INVENTORY: Falsified $19M in non-existent crude-drug inventories and fictitious Canadian warehouse receivables via sham intermediaries, prompting the SEC to mandate physical inventory observation.

Primary Public Dockets & Actions

  • [ENF-1938-mckesson-robbins] Enforcement Action: McKesson & Robbins: $19M Phantom Crude-Drug Inventory & Audit Standards Reform (September 20, 1940): Falsified $19M in non-existent crude-drug inventories and fictitious Canadian warehouse receivables via sham intermediaries, prompting the SEC to mandate physical inventory observation. Official Record ↗